Cargando…

Immunodeficiency in Bloom’s Syndrome

Bloom’s syndrome (BS) is an autosomal recessive disease, caused by mutations in the BLM gene. This gene codes for BLM protein, which is a helicase involved in DNA repair. DNA repair is especially important for the development and maturation of the T and B cells. Since BLM is involved in DNA repair,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoenaker, Michiel H. D., Henriet, Stefanie S., Zonderland, Jip, van Deuren, Marcel, Pan-Hammarström, Qiang, Posthumus-van Sluijs, Sandra J., Pico-Knijnenburg, Ingrid, Weemaes, Corry M. R., IJspeert, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742600/
https://www.ncbi.nlm.nih.gov/pubmed/29098565
http://dx.doi.org/10.1007/s10875-017-0454-y
_version_ 1783288406891036672
author Schoenaker, Michiel H. D.
Henriet, Stefanie S.
Zonderland, Jip
van Deuren, Marcel
Pan-Hammarström, Qiang
Posthumus-van Sluijs, Sandra J.
Pico-Knijnenburg, Ingrid
Weemaes, Corry M. R.
IJspeert, Hanna
author_facet Schoenaker, Michiel H. D.
Henriet, Stefanie S.
Zonderland, Jip
van Deuren, Marcel
Pan-Hammarström, Qiang
Posthumus-van Sluijs, Sandra J.
Pico-Knijnenburg, Ingrid
Weemaes, Corry M. R.
IJspeert, Hanna
author_sort Schoenaker, Michiel H. D.
collection PubMed
description Bloom’s syndrome (BS) is an autosomal recessive disease, caused by mutations in the BLM gene. This gene codes for BLM protein, which is a helicase involved in DNA repair. DNA repair is especially important for the development and maturation of the T and B cells. Since BLM is involved in DNA repair, we aimed to study if BLM deficiency affects T and B cell development and especially somatic hypermutation (SHM) and class switch recombination (CSR) processes. Clinical data of six BS patients was collected, and immunoglobulin serum levels were measured at different time points. In addition, we performed immune phenotyping of the B and T cells and analyzed the SHM and CSR in detail by analyzing IGHA and IGHG transcripts using next-generation sequencing. The serum immunoglobulin levels were relatively low, and patients had an increased number of infections. The absolute number of T, B, and NK cells were low but still in the normal range. Remarkably, all BS patients studied had a high percentage (20–80%) of CD4+ and CD8+ effector memory T cells. The process of SHM seems normal; however, the Ig subclass distribution was not normal, since the BS patients had more IGHG1 and IGHG3 transcripts. In conclusion, BS patients have low number of lymphocytes, but the immunodeficiency seems relatively mild since they have no severe or opportunistic infections. Most changes in the B cell development were seen in the CSR process; however, further studies are necessary to elucidate the exact role of BLM in CSR. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10875-017-0454-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5742600
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-57426002018-01-04 Immunodeficiency in Bloom’s Syndrome Schoenaker, Michiel H. D. Henriet, Stefanie S. Zonderland, Jip van Deuren, Marcel Pan-Hammarström, Qiang Posthumus-van Sluijs, Sandra J. Pico-Knijnenburg, Ingrid Weemaes, Corry M. R. IJspeert, Hanna J Clin Immunol Original Article Bloom’s syndrome (BS) is an autosomal recessive disease, caused by mutations in the BLM gene. This gene codes for BLM protein, which is a helicase involved in DNA repair. DNA repair is especially important for the development and maturation of the T and B cells. Since BLM is involved in DNA repair, we aimed to study if BLM deficiency affects T and B cell development and especially somatic hypermutation (SHM) and class switch recombination (CSR) processes. Clinical data of six BS patients was collected, and immunoglobulin serum levels were measured at different time points. In addition, we performed immune phenotyping of the B and T cells and analyzed the SHM and CSR in detail by analyzing IGHA and IGHG transcripts using next-generation sequencing. The serum immunoglobulin levels were relatively low, and patients had an increased number of infections. The absolute number of T, B, and NK cells were low but still in the normal range. Remarkably, all BS patients studied had a high percentage (20–80%) of CD4+ and CD8+ effector memory T cells. The process of SHM seems normal; however, the Ig subclass distribution was not normal, since the BS patients had more IGHG1 and IGHG3 transcripts. In conclusion, BS patients have low number of lymphocytes, but the immunodeficiency seems relatively mild since they have no severe or opportunistic infections. Most changes in the B cell development were seen in the CSR process; however, further studies are necessary to elucidate the exact role of BLM in CSR. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10875-017-0454-y) contains supplementary material, which is available to authorized users. Springer US 2017-11-02 2018 /pmc/articles/PMC5742600/ /pubmed/29098565 http://dx.doi.org/10.1007/s10875-017-0454-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Schoenaker, Michiel H. D.
Henriet, Stefanie S.
Zonderland, Jip
van Deuren, Marcel
Pan-Hammarström, Qiang
Posthumus-van Sluijs, Sandra J.
Pico-Knijnenburg, Ingrid
Weemaes, Corry M. R.
IJspeert, Hanna
Immunodeficiency in Bloom’s Syndrome
title Immunodeficiency in Bloom’s Syndrome
title_full Immunodeficiency in Bloom’s Syndrome
title_fullStr Immunodeficiency in Bloom’s Syndrome
title_full_unstemmed Immunodeficiency in Bloom’s Syndrome
title_short Immunodeficiency in Bloom’s Syndrome
title_sort immunodeficiency in bloom’s syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742600/
https://www.ncbi.nlm.nih.gov/pubmed/29098565
http://dx.doi.org/10.1007/s10875-017-0454-y
work_keys_str_mv AT schoenakermichielhd immunodeficiencyinbloomssyndrome
AT henrietstefanies immunodeficiencyinbloomssyndrome
AT zonderlandjip immunodeficiencyinbloomssyndrome
AT vandeurenmarcel immunodeficiencyinbloomssyndrome
AT panhammarstromqiang immunodeficiencyinbloomssyndrome
AT posthumusvansluijssandraj immunodeficiencyinbloomssyndrome
AT picoknijnenburgingrid immunodeficiencyinbloomssyndrome
AT weemaescorrymr immunodeficiencyinbloomssyndrome
AT ijspeerthanna immunodeficiencyinbloomssyndrome